Linda King FRSB | |
|---|---|
| Alma mater | University of Liverpool (BSc) University of Oxford (DPhil) |
| Scientific career | |
| Institutions | University of Oxford, Oxford Brookes University |
Linda King FRSB is a virologist in the UK. She is Professor of Virology and Pro Vice-Chancellor for Research and Global Partnerships at Oxford Brookes University.
Education and career[edit]
King was a student at the University of Liverpool graduating with a BSc in Biochemistry and Cell Biology,[1] she studied for her doctorate in molecular virology at the University of Oxford graduating in 1985 and then worked as a postdoctoral researcher and junior research fellow at Linacre College.[2] The following year she moved to Oxford Brookes to work as a lecturer in virology and subsequently rose to professor in 1998.[3]
Research[edit]
King's research looks at insect viruses and focusses on baculovirus expression systems[3] and their use in protein production.
In 1992 she wrote a book with Robert Possee, The Baculovirus Expression Vector System: A Laboratory Guide.[4]
In 2006 King co-founded Oxford Expression Technologies,[5] a spin out company of Oxford Brookes and NERC,[6] which uses a Baculovirus-based protein expression platform to develop mammalian virus vaccines.[7] In 2020 the company is involved in development of 'Covax-19', a vaccine against COVID-19.[8]
References[edit]
- ^ "Linda's Story". www.brookes.ac.uk. Retrieved 15 September 2020.
- ^ "Athena SWAN Charter for women in science" (PDF). www.ecu.ac.uk. Retrieved 15 September 2020.
- ^ a b "Staff Profiles". www.brookes.ac.uk. Retrieved 15 September 2020.
- ^ The Baculovirus Expression System. Springer. ISBN 978-94-010-5047-0.
- ^ "Oxford Expression Technologies Limited". beta.companieshouse.gov.uk. Retrieved 15 September 2020.
- ^ "Meet the Board". oetltd.com. Retrieved 15 September 2020.
- ^ Greenway, Tony (4 March 2020). "Why the insect cell system is a boost for vaccine development". Oxford Mail. Retrieved 15 September 2020.
- ^ Hughes, Tim (4 September 2020). "Coronavirus vaccine may be available next year following grant to Oxford Brookes University's OET". Oxford Mail. Retrieved 15 September 2020.